Latest position paper from EU-CardioRNA: Cardiovascular RNA markers and A.I. may improve COVID-19 outcome

Very happy to share our review just out in CVR from the EU-CardioRNA COST and EU-COVIRNA project team, discussing the potential of RNA biomarkers to monitor risk and prognosis of long-term effects post-SARS-CoV2 infection on the cardiovascular system.

Link to article